As of Apr 23
| -0.075 / -3.33%|
The 6 analysts offering 12-month price forecasts for BioDelivery Sciences International Inc have a median target of 4.75, with a high estimate of 5.00 and a low estimate of 4.00. The median estimate represents a +118.39% increase from the last price of 2.17.
The current consensus among 7 polled investment analysts is to Buy stock in BioDelivery Sciences International Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.